Literature DB >> 29169288

Human studies with microneedles for evaluation of their efficacy and safety.

Thuy Trang Nguyen1, Jung Hwan Park1.   

Abstract

INTRODUCTION: During the past two decades, many studies have documented the development of microneedles (MNs) as a feasible technique for the effective administration of drugs. More and more human studies have been done with MNs to bridge the gap between research and market applications that provide efficacious techniques for clinical implementation. AREAS COVERED: The aim of this review is provide a brief description of the status of human study with MNs and to demonstrate progress for the right use of microneedle arrays in clinical settings. It also describes the considerations for clinical application with each type of MNs. EXPERT OPINION: Microneedle systems were introduced to overcome the limitations of conventional methods of drug administration. Lots of microneedle systems have undergone clinical evaluation to determine their efficacy and safety, and many studies have demonstrated positive results. The successful clinical use of the microneedle in vaccine therapy is remarkable and supports the importance of conducting further tests in a wide range of medical applications. Self-administered MNs appeared to be an attractive alternative method that needs further research to become a reality in the near future.

Entities:  

Keywords:  Microneedle; applied protocol; clinical trials; efficacy; human study; safety

Mesh:

Substances:

Year:  2017        PMID: 29169288     DOI: 10.1080/17425247.2018.1410138

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  14 in total

Review 1.  Microneedle Coating Methods: A Review with a Perspective.

Authors:  Rohan S J Ingrole; Harvinder Singh Gill
Journal:  J Pharmacol Exp Ther       Date:  2019-06-07       Impact factor: 4.030

2.  Plasmonic Paper Microneedle Patch for On-Patch Detection of Molecules in Dermal Interstitial Fluid.

Authors:  Chandana Kolluru; Rohit Gupta; Qisheng Jiang; Mikayla Williams; Hamed Gholami Derami; Sisi Cao; Richard K Noel; Srikanth Singamaneni; Mark R Prausnitz
Journal:  ACS Sens       Date:  2019-05-22       Impact factor: 7.711

3.  Recruitment and Collection of Dermal Interstitial Fluid Using a Microneedle Patch.

Authors:  Chandana Kolluru; Mikayla Williams; Jeremy Chae; Mark R Prausnitz
Journal:  Adv Healthc Mater       Date:  2019-01-04       Impact factor: 9.933

4.  Microneedles coated with peanut allergen enable desensitization of peanut sensitized mice.

Authors:  Akhilesh Kumar Shakya; Rohan S J Ingrole; Gaurav Joshi; Md Jasim Uddin; Sara Anvari; Carla M Davis; Harvinder Singh Gill
Journal:  J Control Release       Date:  2019-10-15       Impact factor: 9.776

Review 5.  Topical and Transdermal Drug Delivery: From Simple Potions to Smart Technologies.

Authors:  Heather A E Benson; Jeffrey E Grice; Yousuf Mohammed; Sarika Namjoshi; Michael S Roberts
Journal:  Curr Drug Deliv       Date:  2019       Impact factor: 2.565

6.  Long-acting reversible contraception by effervescent microneedle patch.

Authors:  Wei Li; Jie Tang; Richard N Terry; Song Li; Aurelie Brunie; Rebecca L Callahan; Richard K Noel; Carlos A Rodríguez; Steven P Schwendeman; Mark R Prausnitz
Journal:  Sci Adv       Date:  2019-11-06       Impact factor: 14.136

Review 7.  A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination.

Authors:  Mark R Prausnitz; James L Goodson; Paul A Rota; Walter A Orenstein
Journal:  Curr Opin Virol       Date:  2020-07-01       Impact factor: 7.090

8.  Progress in microneedle array patch (MAP) for vaccine delivery.

Authors:  Thuy Trang Nguyen; Yujeong Oh; Yunseo Kim; Yura Shin; Seung-Ki Baek; Jung-Hwan Park
Journal:  Hum Vaccin Immunother       Date:  2020-07-15       Impact factor: 3.452

Review 9.  Trends of microneedle technology in the scientific literature, patents, clinical trials and internet activity.

Authors:  Rohan S J Ingrole; Erkan Azizoglu; Maria Dul; James C Birchall; Harvinder S Gill; Mark R Prausnitz
Journal:  Biomaterials       Date:  2020-11-05       Impact factor: 12.479

10.  Cutaneous vaccination ameliorates Zika virus-induced neuro-ocular pathology via reduction of anti-ganglioside antibodies.

Authors:  Jacob T Beaver; Lisa K Mills; Dominika Swieboda; Nadia Lelutiu; Edward S Esser; Olivia Q Antao; Eugenia Scountzou; Dahnide T Williams; Nikolaos Papaioannou; Elizabeth Q Littauer; Andrey Romanyuk; Richard W Compans; Mark R Prausnitz; Ioanna Skountzou
Journal:  Hum Vaccin Immunother       Date:  2020-08-06       Impact factor: 4.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.